217 related articles for article (PubMed ID: 3052245)
21. Patterns of MiB-1 staining of brain tumors: microwave-antigen retrieval as a tool in diagnostic pathology.
Meera G; Jo H; Ravi R
Eur J Morphol; 1995 Nov; 33(4):337-58. PubMed ID: 8835134
[TBL] [Abstract][Full Text] [Related]
22. Expression of a nuclear envelope protein recognized by the monoclonal antibody BU31 in lung tumours: relationship to Ki-67 antigen expression.
Rowlands DC; Bunce CM; Crocker J; Ayres JG; Johnson GD; Ling N; Brown G
J Pathol; 1994 Jun; 173(2):89-96. PubMed ID: 8089810
[TBL] [Abstract][Full Text] [Related]
23. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
[TBL] [Abstract][Full Text] [Related]
24. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
25. Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity.
Prayson RA
Mod Pathol; 1997 Apr; 10(4):304-10. PubMed ID: 9110291
[TBL] [Abstract][Full Text] [Related]
26. Assessment of cell proliferation in paraffin sections of normal bone marrow by the monoclonal antibodies Ki-67 and PCNA.
Budke H; Orazi A; Neiman RS; Cattoretti G; John K; Barberis M
Mod Pathol; 1994 Oct; 7(8):860-6. PubMed ID: 7838840
[TBL] [Abstract][Full Text] [Related]
27. Growth fractions in human prostatic carcinoma determined by Ki-67 immunostaining.
Raymond WA; Leong AS; Bolt JW; Milios J; Jose JS
J Pathol; 1988 Oct; 156(2):161-7. PubMed ID: 3058914
[TBL] [Abstract][Full Text] [Related]
28. PCNA, Ki-67 and hTERT in residual benign meningiomas.
Maes L; Kalala JP; Cornelissen M; De Ridder L
In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
[TBL] [Abstract][Full Text] [Related]
29. MIB-1 immunoreactivity reveals different labelling in low-grade and in malignant epithelial neoplasms of the choroid plexus.
Vajtai I; Varga Z; Aguzzi A
Histopathology; 1996 Aug; 29(2):147-51. PubMed ID: 8872148
[TBL] [Abstract][Full Text] [Related]
30. Different antigen unmasking techniques lead to significant differences in immunohistochemical staining of Ki-67 (Mib-1) in renal cell carcinomas.
Heuschmid M; Hofmockel G; Dexler B; Dämmrich J; Bassukas ID
Oncol Rep; 2002; 9(1):19-22. PubMed ID: 11748449
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
[TBL] [Abstract][Full Text] [Related]
32. An evaluation of the cell cycle-associated monoclonal antibody Ki-S1 as a prognostic factor in primary invasive adenocarcinoma of the breast.
Morris ES; Elston CW; Bell JA; Galea M; Blamey RW; Ellis IO
J Pathol; 1995 May; 176(1):55-62. PubMed ID: 7616357
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies.
Inoue T; Yamane T; Park K; Im T; Tatsumi N; Okuda K
Arch Pathol Lab Med; 1993 Oct; 117(10):969-72. PubMed ID: 8105766
[TBL] [Abstract][Full Text] [Related]
34. [Clinical and experimental studies on the cellular kinetics in esophageal carcinoma by using monoclonal antibody KI-67].
To Y
Nihon Geka Gakkai Zasshi; 1993 Apr; 94(4):341-51. PubMed ID: 8321181
[TBL] [Abstract][Full Text] [Related]
35. Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67.
Knosp E; Kitz K; Perneczky A
Neurosurgery; 1989 Dec; 25(6):927-30. PubMed ID: 2601824
[TBL] [Abstract][Full Text] [Related]
36. Correlation between nucleolar organizer region staining and Ki-67 immunostaining in human gliomas.
Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
Surg Neurol; 1990 May; 33(5):320-4. PubMed ID: 1691866
[TBL] [Abstract][Full Text] [Related]
37. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies.
Gerdes J
Semin Cancer Biol; 1990 Jun; 1(3):199-206. PubMed ID: 2103495
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical demonstration of the KI-67-antigen in paraffin-embedded tumor biopsies.
Böker DK; Stark HJ; Gullotta F; Nadstawek J; Schultheiss R
Clin Neuropathol; 1990; 9(1):51-4. PubMed ID: 2306891
[TBL] [Abstract][Full Text] [Related]
39. Nucleolar organizer region score and Ki-67 labelling index in high-grade gliomas and metastatic brain tumours.
Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
Acta Neurochir (Wien); 1991; 109(1-2):37-41. PubMed ID: 1648862
[TBL] [Abstract][Full Text] [Related]
40. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
